Related Experiment Videos
Antipsychotic medication for challenging behaviour in people with learning disability
1Oxford Down Syndrome Service, Park Hospital for Children, Old Road, Headington, Oxford, UK, OX3.
The Cochrane Database of Systematic Reviews
|July 22, 2004
Summary
Antipsychotic medications show no proven benefit for adults with learning disabilities and challenging behaviors. More research is urgently needed to understand the effectiveness and risks of these drugs.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Challenging behaviors in individuals with learning disabilities can be harmful and limit community access.
- Antipsychotic medications are sometimes used to manage these behaviors, but evidence of their benefit versus risk is limited.
Purpose of the Study:
- To evaluate the effectiveness of antipsychotic medication for individuals with learning disabilities and challenging behaviors, excluding those with co-occurring mental illness.
Main Methods:
- A systematic review of randomized controlled trials comparing antipsychotic medication to placebo was conducted.
- Searches included major biomedical databases, and data were extracted and analyzed on an intention-to-treat basis at 4, 8, and 12 weeks.
Main Results:
- Only nine randomized controlled trials met the inclusion criteria.
- The available data provided no conclusive evidence regarding the efficacy or harm of antipsychotic medications in this population.
Conclusions:
- There is a significant lack of data on the use of antipsychotic medications for challenging behaviors in individuals with learning disabilities.
- Further research is urgently required to address this important clinical question.